MigraineScience by Cerebral Torque

Migraine Science

Retinal Migraine: Vision Loss in One Eye Explained

Posted on June 13 2026, By: Cerebral Torque

Stay in the Loop on the Latest in Migraine:

Retinal Migraine

Vision loss in one eye, why it is so often mislabeled, and how it is actually worked up and treated
Updated June 2026

What Retinal Migraine Is, and the Criteria

Retinal migraine, sometimes called ocular migraine (incorrectly as there is no such diagnosis), is a rare condition where vision changes happen in one eye only, briefly, and are tied in time to a migraine headache. During an attack you may get flashing or shimmering in that eye, a blind spot, dimming, or full loss of vision, lasting minutes, and the vision then returns. The defining word is monocular, meaning one eye, and that single feature is what sets it apart from the far more common visual aura of ordinary migraine, which comes from the brain and affects the same side of vision in both eyes.

Formally it is a diagnosis of exclusion, meaning a doctor confirms it only after ruling out the more dangerous causes of one-eyed vision loss. Under the international headache criteria, the visual symptoms must be fully reversible, confirmed to be one-eyed during an attack (by a visual field test or by the person's own drawing of the blind spot), and accompanied by migraine features such as the disturbance spreading over five minutes or more, lasting five to sixty minutes, and a headache following within an hour.

Quick Definition

Repeated attacks of fully reversible, one-eyed visual disturbance (flashing, blind spot, dimming, or total loss) linked in time to migraine, after other causes of monocular vision loss have been excluded. True retinal migraine is genuinely uncommon, and is over-diagnosed because brain-based aura is so often mistaken for it.

The One-Eye Test (and Why It Is So Easy to Get Wrong)

This is the part that trips up patients and clinicians alike. When vision goes wrong, most people do not stop to cover one eye and check which eye is affected. So a disturbance that is actually in both eyes, a brain-based aura affecting one side of the visual field, gets reported as happening in one eye, simply because that side looked off.

The distinction is not academic, it changes the whole workup. If you can do it safely during an episode, cover one eye and then the other. If the disturbance disappears when you cover the affected eye, it is truly one-eyed and points to the retina or its blood supply. If it persists no matter which eye is covered, the problem is in the brain, not the eye. A careful review article made the point bluntly that most episodes labeled retinal migraine, on closer inspection, are not migraine at all, which is exactly why the one-eye check and a real workup matter so much.

"The single most useful thing you can do during an attack is cover one eye at a time. Whether the vision loss is in one eye or both is the fork in the road for everything that follows." - Cerebral Torque

What Is Happening in the Eye

The honest answer is that the mechanism is not fully settled, but two ideas dominate, and they are not mutually exclusive. The first is vasospasm, a temporary narrowing of the blood vessels that supply the retina or the structures around it, briefly starving the retina of oxygen and causing the vision to drop out. The second is a spreading wave of altered electrical activity across the retina, similar to the cortical spreading depression that produces the visual aura of ordinary migraine, only happening in the retina itself.

The reason this stays monocular comes down to plumbing. Each eye has its own blood supply, and the retina in particular has a dual circulation: the central retinal artery feeding the inner retina, and the choroidal circulation feeding the outer layers and photoreceptors. A disturbance limited to one eye's circulation produces a one-eyed symptom, whereas a brain-based aura, sitting after the optic nerves cross, shows up in both eyes. During documented attacks, narrowing of retinal vessels and reduced blood flow have been observed, and imaging of the retinal circulation can show delayed filling. That vascular element is precisely why some standard migraine drugs, the ones that constrict vessels, are avoided here.

What an Attack Looks Like

Attacks vary widely. Some people get positive symptoms, seeing something extra like flashes or scintillations, while others get negative symptoms, where part or all of the vision in that eye goes dark or missing. In a case series of people diagnosed with retinal migraine, about half described complete vision loss in the affected eye, while others reported blurring, dimming, partial loss, or a blind spot, and more than three quarters had a headache on the same side within about an hour.

1 eye
Where Symptoms Occur
The defining feature, confirmed by covering each eye
5-20 min
Typical Duration
Usually briefer than the visual aura of ordinary migraine
~50%
Family History of Migraine
Many also have a personal history of migraine

Attacks can recur several times in a day in some people, and episodes are usually short. The brevity is one reason treatment focuses on preventing attacks rather than stopping a single one in the moment.

Red Flags: This Can Be an Emergency

This is the most important section in the article. New, sudden loss of vision in one eye is never something to wait out as just a migraine until a professional has examined it, especially the first time it happens.

Sudden one-eyed vision loss needs emergency assessment

Vision loss that feels like a curtain coming down, a shade, or darkness over the eye can be a blocked blood vessel to the eye (central retinal artery occlusion) or a warning sign of stroke, not a migraine. The same picture can come from a clot traveling from the carotid artery or heart, or from giant cell arteritis, an inflammation of the arteries that can permanently blind the eye and needs treatment within hours. Treat sudden monocular vision loss as an emergency and get seen immediately rather than waiting at home.

As a rough guide, migraine-type visual symptoms tend to be positive, like flashing or shimmering, and can occur with or without a headache. Pure darkening or blackout of one eye leans toward a circulation problem and earns a faster, more serious workup. Clinicians would far rather rule out a stroke and find a migraine than the reverse.

The Workup: What Gets Ruled Out and How

Because retinal migraine is a diagnosis of exclusion, the evaluation is really a search for more dangerous causes of transient monocular vision loss. The exact testing is tailored to age and vascular risk, but the usual suspects and the tools used to chase them down look like this.

Conditions to Exclude, and the Typical Evaluation
Amaurosis fugax (carotid or cardiac embolism) Carotid imaging, cardiac source workup
Giant cell arteritis (especially over age 50) ESR and CRP, urgent referral
Optic neuritis or ischemic optic neuropathy Dilated exam, sometimes MRI
Raised intracranial pressure or orbital lesion Fundoscopy, imaging as indicated
Clotting disorders (younger patients) Consider thrombophilia, antiphospholipid testing
Brain-based migraine aura (both eyes) The one-eye history and field testing

A dilated retinal exam looks directly at the vessels and optic nerve, and during or after an attack, imaging of the retinal circulation can occasionally show the delayed filling or vessel narrowing that supports the diagnosis. In an older adult, giant cell arteritis is the can't-miss diagnosis, and inflammatory blood markers should be checked promptly because untreated disease can blind the other eye too. In a younger person without vascular risk, a clotting or autoimmune cause is more on the table.

Triggers

Triggers overlap with ordinary migraine, with an extra emphasis on anything that nudges blood vessels toward narrowing. Knowing yours and steering around them is a real part of management, and a couple of them deserve a specific conversation because of the vascular angle.

Commonly Reported Triggers
Stress and high blood pressure Trigger
Smoking Trigger
Estrogen-containing contraceptives Trigger and vascular risk
Dehydration and low blood sugar Trigger
Exercise, bending over, high altitude, heat Trigger

Because both the condition and some triggers involve blood vessel tone, smoking and estrogen-containing contraception deserve particular attention here, especially alongside other vascular risk factors. Conditions like lupus, atherosclerosis, and sickle cell disease can raise the risk and are worth flagging to your doctor.

Treatment, and the Drugs to Avoid

If attacks are infrequent, say around once a month, no medication may be needed beyond avoiding triggers. When they happen more often, the focus is on prevention rather than aborting a single attack, because the episodes are usually too brief to treat in the moment. The first layer is always the unglamorous one: control blood pressure, stop smoking, address vascular risk, manage triggers, and keep a diary.

When a preventive medication is added, calcium channel blockers are the usual first choice, because they relax blood vessels and counter the vasospasm thought to drive attacks. Verapamil is the most commonly used. Aspirin and certain anti-seizure preventives have also been used in selected cases. It is worth being honest that the evidence base here is thin: retinal migraine is rare, so most guidance rests on case series and expert experience rather than large trials.

Avoid vasoconstrictors: triptans, ergots, and beta-blockers

This is the key treatment point and the biggest difference from ordinary migraine. Because retinal migraine may involve narrowing of the eye's blood vessels, drugs that constrict vessels further are generally avoided, specifically triptans, ergots, and beta-blockers. In this setting they carry a real concern for worsening the blood supply to the eye and, rarely, causing permanent vision loss. Make sure any prescriber knows your visual symptoms are one-eyed, so a triptan is not reached for out of habit.

Quick Reference: Approach, Dosing, and Evidence

A summary of the options above. Doses are typical adult ranges and do not replace prescribing judgment or current labeling. Because retinal migraine is rare, the evidence is mostly low-certainty, drawn from case series and expert practice, and the table reflects that honestly.

Approach Detail / typical dose Rationale Evidence
Risk-factor control Stop smoking; treat hypertension; review estrogen-containing contraception; trigger avoidance; headache diary Addresses the vascular drivers directly Supported
Verapamil (calcium channel blocker) Start low (e.g. ~120 mg/day) and titrate as tolerated toward 240 to 480 mg/day; check for heart block, low blood pressure, constipation Counters retinal vasospasm; first-line preventive Limited
Nifedipine (alternative CCB) Per prescriber; vasodilatory alternative Same vasospasm rationale Limited
Aspirin Low dose (e.g. 75 to 100 mg/day) in selected patients Considered where a thrombotic or vascular component is suspected Limited
Anti-seizure preventive Selected cases per specialist Reported to reduce attack severity in some reports Limited
Triptans, ergots, beta-blockers Generally avoided Vasoconstriction may worsen retinal ischemia and risk permanent vision loss Avoid
Evidence key

Strong randomized trial support. Supported sound rationale plus observational or general-migraine evidence. Limited case-series or expert-level only, which is the norm for this rare condition. Anticoagulation has been used in isolated cases with antiphospholipid syndrome, a specialist decision, not routine care.

Prognosis and Complications

For most people retinal migraine is a benign, manageable condition, and the prognosis is good. The frequency and intensity of attacks tend to settle over time. That said, it is not entirely without risk. Rarely, an episode of retinal, choroidal, or optic nerve oxygen starvation can leave permanent visual loss, and reported complications include central and branch retinal artery occlusion, retinal infarction, and retinal vein occlusion. This small but real possibility is the reason the vasoconstricting drugs are avoided and the reason a first attack deserves a proper workup rather than a wait-and-see.

Talking to Your Doctor, and the Bottom Line

Helpful Things to Bring Up

  • One eye or both: whether the symptoms vanish when you cover the affected eye
  • What you see: flashing and shimmering versus darkening or a curtain
  • Timing: how long it lasts and whether a headache follows
  • Vascular risk: smoking, blood pressure, estrogen-containing contraception, clotting conditions, age over 50
  • Family history: migraine or stroke in close relatives

Retinal migraine is real but rare, and its defining feature, vision loss in a single eye, is also a warning sign for more serious problems, which is why the first episode deserves prompt attention rather than a wait-and-see. Once the dangerous causes are excluded, it is generally benign and managed with vascular risk control and, when needed, a calcium channel blocker like verapamil, while deliberately avoiding the vessel-narrowing drugs used in ordinary migraine. If you have had brief, one-eyed visual episodes, get the workup done. Knowing exactly what you are dealing with is what keeps a benign condition benign.

Important Medical Disclaimer

This article is for education only and is not a substitute for professional medical advice, diagnosis, or treatment. Sudden vision loss in one eye can be a medical emergency. Always consult a qualified healthcare provider, and seek urgent care for new or unexplained vision loss.

References

  1. Al Khalili Y, Jain S, King KC. Retinal Migraine Headache. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023 Jun 26. NIH Bookshelf ID: NBK507725. (PubMed PMID: 29939547)
  2. Grosberg BM, Veronesi M. Retinal migraine. Handb Clin Neurol. 2024;199:381-387. (PubMed PMID: 38307658)
  3. Pradhan S, Chung SM. Retinal, ophthalmic, or ocular migraine. Curr Neurol Neurosci Rep. 2004;4(5):391-397. (PubMed PMID: 15324606)
  4. Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as "retinal migraine" are not migraine. J Neuroophthalmol. 2007;27(1):3-8. (PubMed PMID: 17414865)
  5. Pula JH, Kwan K, Yuen CA, Kattah JC. Update on the evaluation of transient vision loss. Clin Ophthalmol. 2016;10:297-303. (PubMed PMID: 26929593)
  6. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211. (PubMed PMID: 29368949)

Follow Us for Migraine Education and More